Metabolite extract of Streptomyces hygroscopicus Hygroscopicus inhibit the growth of Plasmodium berghei through inhibition of ubiquitin - proteasome system

Streptomyces hygroscopicus Hygroscopicus, a member of family of Actinomycetes produces eponemycin a proteasome inhibitor that can inhibit Ubiquitin-Proteasome System (UPS) function in eukaryotic cell. Previous study showed that coronamycin, an active substrate isolated from Streptomyces sp. can act...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Tropical biomedicine 2013-06, Vol.30 (2), p.291-300
Hauptverfasser: Rivo, Y B, Alkarimah, A, Ramadhani, N N, Cahyono, A W, Laksmi, D A, Winarsih, S, Fitri, L E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 300
container_issue 2
container_start_page 291
container_title Tropical biomedicine
container_volume 30
creator Rivo, Y B
Alkarimah, A
Ramadhani, N N
Cahyono, A W
Laksmi, D A
Winarsih, S
Fitri, L E
description Streptomyces hygroscopicus Hygroscopicus, a member of family of Actinomycetes produces eponemycin a proteasome inhibitor that can inhibit Ubiquitin-Proteasome System (UPS) function in eukaryotic cell. Previous study showed that coronamycin, an active substrate isolated from Streptomyces sp. can act as anti-plasmodial, antibacterial, and antifungal, however the research did not show the mechanism of coronamycin in inhibiting the growth of Plasmodium. This research was done to reveal if eponemycin that is contained in metabolite extract of S. hygroscopicus can inhibit UPS function of Plasmodium berghei. This study was an experimental study using P. berghei infected Balb/C mice as malaria model. Samples were divided into 1 control group (group infected with P. berghei without treatment) and 3 treatment groups (mice infected with P. berghei and treated intra-peritoneal with metabolite extract of S. hygroscopicus dose 130 μg/kgBW, 580 μg/kgBW, and 2600 μg/kgBW for 5 days). The degree of parasitemia and morphology of the parasite were measured from the first day of malaria induction until the last treatment. The accumulation level of polyubiquitin was measured using Western blot and ELISA method. The degree of parasitemia on day 6 showed significant differences among treatment groups and control (p=0,000). Percentage of inhibition showed significant differences between control and group treated with metabolite extract of S. hygroscopicus 2600 μg/kgBW. An increasing dose of extract of S. hygroscopicus followed by an increasing of inhibition in parasite growth (r=0,850). Probit analysis showed that ED50 was 9.418 μg/kgBW. There was a change in morphology of the parasite after treatment. Parasite morphology became crisis form. There was an accumulation of polyubiquitinated protein in the group treated with metabolite extract of S. hygroscopicus 2600 μg/kgBW. It can be concluded that analog eponemycin in metabolite of S. hygroscopicus is a potential candidate for new malarial drug by inhibiting UPS function of the parasite and cause stress and dead of the parasite.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1426749845</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1426749845</sourcerecordid><originalsourceid>FETCH-LOGICAL-p211t-55ecaa319b49d86a8a789dce7f64e5668d1545dd50027957f893ad1d402667153</originalsourceid><addsrcrecordid>eNpVkM1OwzAQhHMA0VJ4BeQjl0hxYsf2EVVAkYpAAs6RE28aozhO_SPIs_CypKI9cFrN6pvRaM6SZYZzllKWZ4vk0vvPLKOEc3KRLPJCUEEEXSY_zxBkbXsdAMF3cLIJyLboLTgYgzVTAx51085Z39hRN9GjzT-lh07XOqDQAZr_X6E72F976Y1VOhpUg9t1oGfA2bjrTgZthwMYa72PsxpQikZnA0hvDSA_-QDmKjlvZe_h-nhXycfD_ft6k25fHp_Wd9t0zDEOKaXQSFlgUROheCm5ZFyoBlhbEqBlyRWmhCpFsyxngrKWi0IqrEiWlyXDtFglt3-5c4N9BB8qo30DfS8HsNFXmOQlI4KTA3pzRGNtQFWj00a6qToNWvwCInh1YA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1426749845</pqid></control><display><type>article</type><title>Metabolite extract of Streptomyces hygroscopicus Hygroscopicus inhibit the growth of Plasmodium berghei through inhibition of ubiquitin - proteasome system</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Rivo, Y B ; Alkarimah, A ; Ramadhani, N N ; Cahyono, A W ; Laksmi, D A ; Winarsih, S ; Fitri, L E</creator><creatorcontrib>Rivo, Y B ; Alkarimah, A ; Ramadhani, N N ; Cahyono, A W ; Laksmi, D A ; Winarsih, S ; Fitri, L E</creatorcontrib><description>Streptomyces hygroscopicus Hygroscopicus, a member of family of Actinomycetes produces eponemycin a proteasome inhibitor that can inhibit Ubiquitin-Proteasome System (UPS) function in eukaryotic cell. Previous study showed that coronamycin, an active substrate isolated from Streptomyces sp. can act as anti-plasmodial, antibacterial, and antifungal, however the research did not show the mechanism of coronamycin in inhibiting the growth of Plasmodium. This research was done to reveal if eponemycin that is contained in metabolite extract of S. hygroscopicus can inhibit UPS function of Plasmodium berghei. This study was an experimental study using P. berghei infected Balb/C mice as malaria model. Samples were divided into 1 control group (group infected with P. berghei without treatment) and 3 treatment groups (mice infected with P. berghei and treated intra-peritoneal with metabolite extract of S. hygroscopicus dose 130 μg/kgBW, 580 μg/kgBW, and 2600 μg/kgBW for 5 days). The degree of parasitemia and morphology of the parasite were measured from the first day of malaria induction until the last treatment. The accumulation level of polyubiquitin was measured using Western blot and ELISA method. The degree of parasitemia on day 6 showed significant differences among treatment groups and control (p=0,000). Percentage of inhibition showed significant differences between control and group treated with metabolite extract of S. hygroscopicus 2600 μg/kgBW. An increasing dose of extract of S. hygroscopicus followed by an increasing of inhibition in parasite growth (r=0,850). Probit analysis showed that ED50 was 9.418 μg/kgBW. There was a change in morphology of the parasite after treatment. Parasite morphology became crisis form. There was an accumulation of polyubiquitinated protein in the group treated with metabolite extract of S. hygroscopicus 2600 μg/kgBW. It can be concluded that analog eponemycin in metabolite of S. hygroscopicus is a potential candidate for new malarial drug by inhibiting UPS function of the parasite and cause stress and dead of the parasite.</description><identifier>ISSN: 0127-5720</identifier><identifier>PMID: 23959495</identifier><language>eng</language><publisher>Malaysia</publisher><subject>Animals ; Antimalarials - isolation &amp; purification ; Antimalarials - therapeutic use ; Blotting, Western ; Disease Models, Animal ; Enzyme Inhibitors - isolation &amp; purification ; Enzyme Inhibitors - therapeutic use ; Enzyme-Linked Immunosorbent Assay ; Malaria - drug therapy ; Malaria - parasitology ; Male ; Mice ; Mice, Inbred BALB C ; Parasitemia - drug therapy ; Parasitemia - parasitology ; Plasmodium ; Plasmodium berghei - cytology ; Plasmodium berghei - drug effects ; Polyubiquitin - analysis ; Proteasome Endopeptidase Complex - drug effects ; Streptomyces - metabolism ; Treatment Outcome ; Ubiquitin - antagonists &amp; inhibitors</subject><ispartof>Tropical biomedicine, 2013-06, Vol.30 (2), p.291-300</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23959495$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rivo, Y B</creatorcontrib><creatorcontrib>Alkarimah, A</creatorcontrib><creatorcontrib>Ramadhani, N N</creatorcontrib><creatorcontrib>Cahyono, A W</creatorcontrib><creatorcontrib>Laksmi, D A</creatorcontrib><creatorcontrib>Winarsih, S</creatorcontrib><creatorcontrib>Fitri, L E</creatorcontrib><title>Metabolite extract of Streptomyces hygroscopicus Hygroscopicus inhibit the growth of Plasmodium berghei through inhibition of ubiquitin - proteasome system</title><title>Tropical biomedicine</title><addtitle>Trop Biomed</addtitle><description>Streptomyces hygroscopicus Hygroscopicus, a member of family of Actinomycetes produces eponemycin a proteasome inhibitor that can inhibit Ubiquitin-Proteasome System (UPS) function in eukaryotic cell. Previous study showed that coronamycin, an active substrate isolated from Streptomyces sp. can act as anti-plasmodial, antibacterial, and antifungal, however the research did not show the mechanism of coronamycin in inhibiting the growth of Plasmodium. This research was done to reveal if eponemycin that is contained in metabolite extract of S. hygroscopicus can inhibit UPS function of Plasmodium berghei. This study was an experimental study using P. berghei infected Balb/C mice as malaria model. Samples were divided into 1 control group (group infected with P. berghei without treatment) and 3 treatment groups (mice infected with P. berghei and treated intra-peritoneal with metabolite extract of S. hygroscopicus dose 130 μg/kgBW, 580 μg/kgBW, and 2600 μg/kgBW for 5 days). The degree of parasitemia and morphology of the parasite were measured from the first day of malaria induction until the last treatment. The accumulation level of polyubiquitin was measured using Western blot and ELISA method. The degree of parasitemia on day 6 showed significant differences among treatment groups and control (p=0,000). Percentage of inhibition showed significant differences between control and group treated with metabolite extract of S. hygroscopicus 2600 μg/kgBW. An increasing dose of extract of S. hygroscopicus followed by an increasing of inhibition in parasite growth (r=0,850). Probit analysis showed that ED50 was 9.418 μg/kgBW. There was a change in morphology of the parasite after treatment. Parasite morphology became crisis form. There was an accumulation of polyubiquitinated protein in the group treated with metabolite extract of S. hygroscopicus 2600 μg/kgBW. It can be concluded that analog eponemycin in metabolite of S. hygroscopicus is a potential candidate for new malarial drug by inhibiting UPS function of the parasite and cause stress and dead of the parasite.</description><subject>Animals</subject><subject>Antimalarials - isolation &amp; purification</subject><subject>Antimalarials - therapeutic use</subject><subject>Blotting, Western</subject><subject>Disease Models, Animal</subject><subject>Enzyme Inhibitors - isolation &amp; purification</subject><subject>Enzyme Inhibitors - therapeutic use</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Malaria - drug therapy</subject><subject>Malaria - parasitology</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Parasitemia - drug therapy</subject><subject>Parasitemia - parasitology</subject><subject>Plasmodium</subject><subject>Plasmodium berghei - cytology</subject><subject>Plasmodium berghei - drug effects</subject><subject>Polyubiquitin - analysis</subject><subject>Proteasome Endopeptidase Complex - drug effects</subject><subject>Streptomyces - metabolism</subject><subject>Treatment Outcome</subject><subject>Ubiquitin - antagonists &amp; inhibitors</subject><issn>0127-5720</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkM1OwzAQhHMA0VJ4BeQjl0hxYsf2EVVAkYpAAs6RE28aozhO_SPIs_CypKI9cFrN6pvRaM6SZYZzllKWZ4vk0vvPLKOEc3KRLPJCUEEEXSY_zxBkbXsdAMF3cLIJyLboLTgYgzVTAx51085Z39hRN9GjzT-lh07XOqDQAZr_X6E72F976Y1VOhpUg9t1oGfA2bjrTgZthwMYa72PsxpQikZnA0hvDSA_-QDmKjlvZe_h-nhXycfD_ft6k25fHp_Wd9t0zDEOKaXQSFlgUROheCm5ZFyoBlhbEqBlyRWmhCpFsyxngrKWi0IqrEiWlyXDtFglt3-5c4N9BB8qo30DfS8HsNFXmOQlI4KTA3pzRGNtQFWj00a6qToNWvwCInh1YA</recordid><startdate>201306</startdate><enddate>201306</enddate><creator>Rivo, Y B</creator><creator>Alkarimah, A</creator><creator>Ramadhani, N N</creator><creator>Cahyono, A W</creator><creator>Laksmi, D A</creator><creator>Winarsih, S</creator><creator>Fitri, L E</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201306</creationdate><title>Metabolite extract of Streptomyces hygroscopicus Hygroscopicus inhibit the growth of Plasmodium berghei through inhibition of ubiquitin - proteasome system</title><author>Rivo, Y B ; Alkarimah, A ; Ramadhani, N N ; Cahyono, A W ; Laksmi, D A ; Winarsih, S ; Fitri, L E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p211t-55ecaa319b49d86a8a789dce7f64e5668d1545dd50027957f893ad1d402667153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Animals</topic><topic>Antimalarials - isolation &amp; purification</topic><topic>Antimalarials - therapeutic use</topic><topic>Blotting, Western</topic><topic>Disease Models, Animal</topic><topic>Enzyme Inhibitors - isolation &amp; purification</topic><topic>Enzyme Inhibitors - therapeutic use</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Malaria - drug therapy</topic><topic>Malaria - parasitology</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Parasitemia - drug therapy</topic><topic>Parasitemia - parasitology</topic><topic>Plasmodium</topic><topic>Plasmodium berghei - cytology</topic><topic>Plasmodium berghei - drug effects</topic><topic>Polyubiquitin - analysis</topic><topic>Proteasome Endopeptidase Complex - drug effects</topic><topic>Streptomyces - metabolism</topic><topic>Treatment Outcome</topic><topic>Ubiquitin - antagonists &amp; inhibitors</topic><toplevel>online_resources</toplevel><creatorcontrib>Rivo, Y B</creatorcontrib><creatorcontrib>Alkarimah, A</creatorcontrib><creatorcontrib>Ramadhani, N N</creatorcontrib><creatorcontrib>Cahyono, A W</creatorcontrib><creatorcontrib>Laksmi, D A</creatorcontrib><creatorcontrib>Winarsih, S</creatorcontrib><creatorcontrib>Fitri, L E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Tropical biomedicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rivo, Y B</au><au>Alkarimah, A</au><au>Ramadhani, N N</au><au>Cahyono, A W</au><au>Laksmi, D A</au><au>Winarsih, S</au><au>Fitri, L E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolite extract of Streptomyces hygroscopicus Hygroscopicus inhibit the growth of Plasmodium berghei through inhibition of ubiquitin - proteasome system</atitle><jtitle>Tropical biomedicine</jtitle><addtitle>Trop Biomed</addtitle><date>2013-06</date><risdate>2013</risdate><volume>30</volume><issue>2</issue><spage>291</spage><epage>300</epage><pages>291-300</pages><issn>0127-5720</issn><abstract>Streptomyces hygroscopicus Hygroscopicus, a member of family of Actinomycetes produces eponemycin a proteasome inhibitor that can inhibit Ubiquitin-Proteasome System (UPS) function in eukaryotic cell. Previous study showed that coronamycin, an active substrate isolated from Streptomyces sp. can act as anti-plasmodial, antibacterial, and antifungal, however the research did not show the mechanism of coronamycin in inhibiting the growth of Plasmodium. This research was done to reveal if eponemycin that is contained in metabolite extract of S. hygroscopicus can inhibit UPS function of Plasmodium berghei. This study was an experimental study using P. berghei infected Balb/C mice as malaria model. Samples were divided into 1 control group (group infected with P. berghei without treatment) and 3 treatment groups (mice infected with P. berghei and treated intra-peritoneal with metabolite extract of S. hygroscopicus dose 130 μg/kgBW, 580 μg/kgBW, and 2600 μg/kgBW for 5 days). The degree of parasitemia and morphology of the parasite were measured from the first day of malaria induction until the last treatment. The accumulation level of polyubiquitin was measured using Western blot and ELISA method. The degree of parasitemia on day 6 showed significant differences among treatment groups and control (p=0,000). Percentage of inhibition showed significant differences between control and group treated with metabolite extract of S. hygroscopicus 2600 μg/kgBW. An increasing dose of extract of S. hygroscopicus followed by an increasing of inhibition in parasite growth (r=0,850). Probit analysis showed that ED50 was 9.418 μg/kgBW. There was a change in morphology of the parasite after treatment. Parasite morphology became crisis form. There was an accumulation of polyubiquitinated protein in the group treated with metabolite extract of S. hygroscopicus 2600 μg/kgBW. It can be concluded that analog eponemycin in metabolite of S. hygroscopicus is a potential candidate for new malarial drug by inhibiting UPS function of the parasite and cause stress and dead of the parasite.</abstract><cop>Malaysia</cop><pmid>23959495</pmid><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0127-5720
ispartof Tropical biomedicine, 2013-06, Vol.30 (2), p.291-300
issn 0127-5720
language eng
recordid cdi_proquest_miscellaneous_1426749845
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Animals
Antimalarials - isolation & purification
Antimalarials - therapeutic use
Blotting, Western
Disease Models, Animal
Enzyme Inhibitors - isolation & purification
Enzyme Inhibitors - therapeutic use
Enzyme-Linked Immunosorbent Assay
Malaria - drug therapy
Malaria - parasitology
Male
Mice
Mice, Inbred BALB C
Parasitemia - drug therapy
Parasitemia - parasitology
Plasmodium
Plasmodium berghei - cytology
Plasmodium berghei - drug effects
Polyubiquitin - analysis
Proteasome Endopeptidase Complex - drug effects
Streptomyces - metabolism
Treatment Outcome
Ubiquitin - antagonists & inhibitors
title Metabolite extract of Streptomyces hygroscopicus Hygroscopicus inhibit the growth of Plasmodium berghei through inhibition of ubiquitin - proteasome system
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T07%3A30%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolite%20extract%20of%20Streptomyces%20hygroscopicus%20Hygroscopicus%20inhibit%20the%20growth%20of%20Plasmodium%20berghei%20through%20inhibition%20of%20ubiquitin%20-%20proteasome%20system&rft.jtitle=Tropical%20biomedicine&rft.au=Rivo,%20Y%20B&rft.date=2013-06&rft.volume=30&rft.issue=2&rft.spage=291&rft.epage=300&rft.pages=291-300&rft.issn=0127-5720&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E1426749845%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1426749845&rft_id=info:pmid/23959495&rfr_iscdi=true